Results 201 to 210 of about 76,843 (254)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

Nature Network Boston, 2004
H. McShane, A. Pathan, C. Sander, S. Keating, S. Gilbert, K. Huygen, H. Fletcher, A. Hill   +7 more
semanticscholar   +1 more source

Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir. [PDF]

Signal Transduct Target Ther
Zhang Y, Wan Y, Guo C, Zhu Z, Qiu C, Lu J, Zhou Y, Zheng J, Dai F, Cheng X, Deng K, Wang W, Wang Y, Zhang W.   +13 more
europepmc   +1 more source

A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus

Nature Biotechnology, 2006
Magdalini Moutaftsi, Bjoern Peters, V. Pasquetto, D. Tscharke, J. Sidney, H. Bui, H. Grey, A. Sette   +7 more
semanticscholar   +1 more source

Robust polyfunctional CD8⁺ and CD4⁺ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein. [PDF]

J Gen Virol
Tscherne A, Kalodimou G, Jany S, Freudenstein A, Kumar S, Pilchová V, Friebis T, Maiwald G, Panhofer I, Sutter G, Volz A.   +10 more
europepmc   +1 more source

Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. [PDF]

MMWR Morb Mortal Wkly Rep
Rao AK, Minhaj FS, Carter RJ, Duffy J, Satheshkumar PS, Delaney KP, Quilter LAS, Kachur RE, McLean C, Moulia DL, Kuhar DT, de Perio MA, Spicknall IH, Bell BP, Sánchez PJ, Hutson CL, Cohn AC.   +16 more
europepmc   +1 more source

Studies on the hemagglutination by vaccinia

, 1953
Isamu TAGAYA
openalex   +2 more sources

Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection. [PDF]

PLoS Pathog
Zhang L, Liu C, Yang C, Xiao X, Xu S, Wan S, Xu K, Li Y, Dai L.   +8 more
europepmc   +1 more source

Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development. [PDF]

Virulence
Zhang Y, Hou R, Wei Z, Yuan J, Zu S.
europepmc   +1 more source

Experimental study on the meaning of transformation small-pox into vaccinia

, 1950
Kyuzo SATO, Tadashi Sato
openalex   +2 more sources